Innocoll Holdings plc to Present at the Stifel 2016 Healthcare Conference
November 14 2016 - 7:30AM
Innocoll Holdings plc (Nasdaq:INNL), a global, specialty
pharmaceutical and medical device company with late stage
development programs targeting areas of significant unmet medical
need, today announced that Anthony Zook, Chief Executive Officer of
Innocoll Holdings plc, will participate in a fireside chat at the
Stifel 2016 Healthcare Conference on Wednesday, November 16, 2016,
at 8:45 a.m. ET at the Lotte New York Palace Hotel in New York,
NY.
About Innocoll Holdings plc
Innocoll is a global, specialty pharmaceutical
company with late stage development programs that is dedicated to
engineering better medicines to help patients get better. Our
proprietary, biocompatible, and biodegradable collagen products are
precision-engineered for targeted use. Applied locally to surgery
sites, they are designed to provide a range of benefits. The
company's late stage product pipeline is focused on addressing a
number of large unmet medical needs, including: XARACOLL for the
treatment of postoperative pain and COLLAGUARD (INL-003), a barrier
for the prevention of post-surgical adhesions.
Our currently approved products include:
COLLAGUARD® (ex-US), COLLATAMP® G, SEPTOCOLL® E, REGENEPRO®,
COLLACARE®, COLLEXA®, and ZORPREVA®.
Corporate:
Pepe Carmona
Chief Financial Officer
(215) 983-3362
pcarmona@innocoll.com
Jeannie Sorenson, M.D.
Vice President, Investor Relations
(314) 458-7355
jsorenson@innocoll.com
Innocoll AG (NASDAQ:INNL)
Historical Stock Chart
From Apr 2024 to May 2024
Innocoll AG (NASDAQ:INNL)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Innocoll Holdings - Ordinary Shares (MM) (NASDAQ): 0 recent articles
More News Articles